preview

Encephalitis Essay

Decent Essays

The first crude mouse brain derived inactivated Japanese Encephalitis (JE) vaccines were produced in the 1930s by the Japanese and Russians, and similar vaccines were used for the U.S. armies during the world war II (1). The first Nakayama strain based inactivated mouse brain-derived (IMB) JE vaccine was licensed in Japan in 1954 (2) and in the United States in 1992 (3). It then became the most widely used JE vaccine internationally and was also a part of the routine immunization programs in some Asian countries (4). However, concerns appeared regarding temporal association of rare, but severe, neurological adverse events with this vaccine, despite the lack of causal association (5,6). In 2006, WHO recommended this vaccine to be eventually …show more content…

A single dose is administered at ≥9 months of age (10) while the booster dose recommendation have not yet been determined(5).
Immunological basis for vaccine efficacy and protection duration
Protection from all the vaccine is based on sufficient neutralizing antibodies (10). There are no concerns about a deficiency for cross-protection across the five genotypes so far (7). JE vaccine doesn’t induce herd immunity (10).
Inactivated Vero cell-derived vaccines: Seroprotection rates as high as 99% has been observed in non-endemic settings (7). Whereas, a seroprotection rate of 95.7% to >99% have been reported among children in endemic settings (10). Sustained seroprotection (90%) were noted even after three years in endemic-(6) and after two years in non-endemic (13) pediatric population. The seroprotection seems to wane over time but a booster dose has proven to be effective for protective seroconversion (14).
Live attenuated vaccines:
Several safety studies from China have shown that this vaccine is safe (15) with no indication of viral reversion to a neurovirulent phenotype (8). Sustained seroprotection has been observed; 98% by the end of 1 year (16) and 96% by the end of 5 years (17) after the initial vaccination with a single dose in endemic setting.
Live recombinant vaccine:
A recent study showed that there were no safety concerns in children

Get Access